EP Patent

EP2386289A1 — Clay compositions

Assigned to Ipsen Pharma SAS · Expires 2011-11-16 · 15y expired

What this patent protects

The present invention relates to liquid or semi-solid pharmaceutical compositions, more specifically to aqueous pharmaceutical suspension or semi-solid paste containing natural mineral clays. These compositions are particularly useful for the treatment of acute and chronic diarrh…

USPTO Abstract

The present invention relates to liquid or semi-solid pharmaceutical compositions, more specifically to aqueous pharmaceutical suspension or semi-solid paste containing natural mineral clays. These compositions are particularly useful for the treatment of acute and chronic diarrhoea.

Drugs covered by this patent

Patent Metadata

Patent number
EP2386289A1
Jurisdiction
EP
Classification
—
Expires
2011-11-16
Drug substance claim
No
Drug product claim
No
Assignee
Ipsen Pharma SAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.